Detecting Alzheimer’s
When it Still Matters.
A scalable platform combining clinical data and cognitive assessments with Retinal Hyperspectral Imaging (HSI)
to identify Alzheimer’s Disease years in advance, before the brain damages become irreversible.
Non-invasive. Accessible. Precise.
Why standard care is not enough
The diagnostic window is currently missed by decades.
Too Late
Diagnosis typically happens after symptom onset, when neurological damage is often irreversible.
Too Invasive
PET scans and Lumbar Punctures are painful, complex, expensive, and not scalable for mass screening.
The AlzhAI Solution
We are the precise tool that does not wait for symptoms to appear.
We offer a non-invasive window into the brain through Retinal HSI.
Empowering the Ecosystem
💊 Pharmaceutical Companies
We are providing pharmaceutical teams with an efficient tool to monitor treatment trends and streamline patient selection—cutting both time and costs in study development.
🏥 Clinical Centers
Enhance workflow efficiency. Screen thousands of patients non-invasively and prioritize high-risk individuals for expensive and deeper examinations.